Nucleic Acid Sample Preparation Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product, By Technology, By Therapeutic Area, By Application, By End Users, By Region & Competition, 2021-2031F

Description

The Global Nucleic Acid Sample Preparation Market is projected to expand from USD 2.99 Billion in 2025 to USD 4.41 Billion by 2031, achieving a 6.69% Compound Annual Growth Rate. This market centers on the extraction, isolation, and purification of DNA and RNA from biological samples to yield high-quality material for critical downstream analytical uses like amplification and sequencing.

Market Overview
Forecast Period	2027-2031
Market Size 2025	USD 2.99 Billion
Market Size 2031	USD 4.41 Billion
CAGR 2026-2031	6.69%
Fastest Growing Segment	Genomics
Largest Market	North America

Market Driver

Key drivers for this expansion include the rising incidence of infectious diseases and cancer, demanding extensive molecular diagnostic testing, and the burgeoning field of precision medicine, which requires reliable, high-purity nucleic acid extraction for accurate genomic profiling. The substantial demand for sample processing within biopharmaceutical research is further evidenced by over 8,000 medicines in clinical development in 2024. Furthermore, the increasing adoption of Next-Generation Sequencing and molecular diagnostics is fueling market growth by imposing stringent quality standards on extracted nucleic acids for generating reliable data in areas such as liquid biopsy.

Market Challenge

Despite these robust growth factors, the Global Nucleic Acid Sample Preparation Market faces a significant impediment due to the high capital investment required for automated nucleic acid extraction platforms. This substantial initial expenditure often proves prohibitive for smaller laboratories and diagnostic centers, which are then compelled to rely on less efficient, labor-intensive manual extraction methods. Such budgetary constraints directly limit market penetration for advanced technologies and concentrate their adoption within larger, well-funded reference laboratories. Evidence from the American Hospital Association in 2025 indicates that 94% of healthcare administrators anticipated delaying equipment upgrades due to persistent financial strain, underscoring how this widespread deferral of capital projects impedes the market by extending the lifecycle of legacy equipment rather than fostering investment in modern automated workflows essential for scaling genomic profiling and diagnostic testing.

Market Trends

Complementing this growth, the market is experiencing an increase in the adoption of automated liquid handling workstations, which enhance reproducibility and operational efficiency by standardizing nucleic acid yields and reducing manual effort, alongside the development of high-precision kits for single-cell genomics, critical for isolating genetic material from individual cells for advanced applications in immunology and spatial biology.

Key Market Players

BGI Group
F. Hoffmann-La Roche Ltd
Danaher Corporation
Eppendorf SE
BIONEER CORPORATION
Endress+Hauser Group Services AG
Merck KGaA
Norgen Biotek Corp.
Aurora Biomed Inc.
Agilent Technologies, Inc.

Report Scope

In this report, the Global Nucleic Acid Sample Preparation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Nucleic Acid Sample Preparation Market, By Product

Consumables
Systems
Accessories & Components

Nucleic Acid Sample Preparation Market, By Technology

Spin-Column Based Technology
Magnetic-Bead Based Technology
Others

Nucleic Acid Sample Preparation Market, By Therapeutic Area

Oncology
Infectious Disease
Human Genetics/Population Genetics
Others

Nucleic Acid Sample Preparation Market, By Application

Genomics
Proteomics
Others

Nucleic Acid Sample Preparation Market, By End Users

Academic and Research Institutions
Pharmaceutical and Biotechnology Companies
Clinical and Diagnostic Laboratories
Other

Nucleic Acid Sample Preparation Market, By Region

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Nucleic Acid Sample Preparation Market.

Available Customizations:

Global Nucleic Acid Sample Preparation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Nucleic Acid Sample Preparation Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Product (Consumables, Systems, Accessories & Components)
- 5.2.2. By Technology (Spin-Column Based Technology, Magnetic-Bead Based Technology, Others)
- 5.2.3. By Therapeutic Area (Oncology, Infectious Disease, Human Genetics/Population Genetics, Others)
- 5.2.4. By Application (Genomics, Proteomics, Others)
- 5.2.5. By End Users (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Other)
- 5.2.6. By Region
- 5.2.7. By Company (2025)
5.3. Market Map

6. North America Nucleic Acid Sample Preparation Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Product
- 6.2.2. By Technology
- 6.2.3. By Therapeutic Area
- 6.2.4. By Application
- 6.2.5. By End Users
- 6.2.6. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Nucleic Acid Sample Preparation Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Product
    - 6.3.1.2.2. By Technology
    - 6.3.1.2.3. By Therapeutic Area
    - 6.3.1.2.4. By Application
    - 6.3.1.2.5. By End Users
- 6.3.2. Canada Nucleic Acid Sample Preparation Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Product
    - 6.3.2.2.2. By Technology
    - 6.3.2.2.3. By Therapeutic Area
    - 6.3.2.2.4. By Application
    - 6.3.2.2.5. By End Users
- 6.3.3. Mexico Nucleic Acid Sample Preparation Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Product
    - 6.3.3.2.2. By Technology
    - 6.3.3.2.3. By Therapeutic Area
    - 6.3.3.2.4. By Application
    - 6.3.3.2.5. By End Users

7. Europe Nucleic Acid Sample Preparation Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Product
- 7.2.2. By Technology
- 7.2.3. By Therapeutic Area
- 7.2.4. By Application
- 7.2.5. By End Users
- 7.2.6. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Nucleic Acid Sample Preparation Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Product
    - 7.3.1.2.2. By Technology
    - 7.3.1.2.3. By Therapeutic Area
    - 7.3.1.2.4. By Application
    - 7.3.1.2.5. By End Users
- 7.3.2. France Nucleic Acid Sample Preparation Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Product
    - 7.3.2.2.2. By Technology
    - 7.3.2.2.3. By Therapeutic Area
    - 7.3.2.2.4. By Application
    - 7.3.2.2.5. By End Users
- 7.3.3. United Kingdom Nucleic Acid Sample Preparation Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Product
    - 7.3.3.2.2. By Technology
    - 7.3.3.2.3. By Therapeutic Area
    - 7.3.3.2.4. By Application
    - 7.3.3.2.5. By End Users
- 7.3.4. Italy Nucleic Acid Sample Preparation Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Product
    - 7.3.4.2.2. By Technology
    - 7.3.4.2.3. By Therapeutic Area
    - 7.3.4.2.4. By Application
    - 7.3.4.2.5. By End Users
- 7.3.5. Spain Nucleic Acid Sample Preparation Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Product
    - 7.3.5.2.2. By Technology
    - 7.3.5.2.3. By Therapeutic Area
    - 7.3.5.2.4. By Application
    - 7.3.5.2.5. By End Users

8. Asia Pacific Nucleic Acid Sample Preparation Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Product
- 8.2.2. By Technology
- 8.2.3. By Therapeutic Area
- 8.2.4. By Application
- 8.2.5. By End Users
- 8.2.6. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Nucleic Acid Sample Preparation Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Product
    - 8.3.1.2.2. By Technology
    - 8.3.1.2.3. By Therapeutic Area
    - 8.3.1.2.4. By Application
    - 8.3.1.2.5. By End Users
- 8.3.2. India Nucleic Acid Sample Preparation Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Product
    - 8.3.2.2.2. By Technology
    - 8.3.2.2.3. By Therapeutic Area
    - 8.3.2.2.4. By Application
    - 8.3.2.2.5. By End Users
- 8.3.3. Japan Nucleic Acid Sample Preparation Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Product
    - 8.3.3.2.2. By Technology
    - 8.3.3.2.3. By Therapeutic Area
    - 8.3.3.2.4. By Application
    - 8.3.3.2.5. By End Users
- 8.3.4. South Korea Nucleic Acid Sample Preparation Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Product
    - 8.3.4.2.2. By Technology
    - 8.3.4.2.3. By Therapeutic Area
    - 8.3.4.2.4. By Application
    - 8.3.4.2.5. By End Users
- 8.3.5. Australia Nucleic Acid Sample Preparation Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Product
    - 8.3.5.2.2. By Technology
    - 8.3.5.2.3. By Therapeutic Area
    - 8.3.5.2.4. By Application
    - 8.3.5.2.5. By End Users

9. Middle East & Africa Nucleic Acid Sample Preparation Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Product
- 9.2.2. By Technology
- 9.2.3. By Therapeutic Area
- 9.2.4. By Application
- 9.2.5. By End Users
- 9.2.6. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Nucleic Acid Sample Preparation Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Product
    - 9.3.1.2.2. By Technology
    - 9.3.1.2.3. By Therapeutic Area
    - 9.3.1.2.4. By Application
    - 9.3.1.2.5. By End Users
- 9.3.2. UAE Nucleic Acid Sample Preparation Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Product
    - 9.3.2.2.2. By Technology
    - 9.3.2.2.3. By Therapeutic Area
    - 9.3.2.2.4. By Application
    - 9.3.2.2.5. By End Users
- 9.3.3. South Africa Nucleic Acid Sample Preparation Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Product
    - 9.3.3.2.2. By Technology
    - 9.3.3.2.3. By Therapeutic Area
    - 9.3.3.2.4. By Application
    - 9.3.3.2.5. By End Users

10. South America Nucleic Acid Sample Preparation Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Product
- 10.2.2. By Technology
- 10.2.3. By Therapeutic Area
- 10.2.4. By Application
- 10.2.5. By End Users
- 10.2.6. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Nucleic Acid Sample Preparation Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Product
    - 10.3.1.2.2. By Technology
    - 10.3.1.2.3. By Therapeutic Area
    - 10.3.1.2.4. By Application
    - 10.3.1.2.5. By End Users
- 10.3.2. Colombia Nucleic Acid Sample Preparation Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Product
    - 10.3.2.2.2. By Technology
    - 10.3.2.2.3. By Therapeutic Area
    - 10.3.2.2.4. By Application
    - 10.3.2.2.5. By End Users
- 10.3.3. Argentina Nucleic Acid Sample Preparation Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Product
    - 10.3.3.2.2. By Technology
    - 10.3.3.2.3. By Therapeutic Area
    - 10.3.3.2.4. By Application
    - 10.3.3.2.5. By End Users

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Nucleic Acid Sample Preparation Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. BGI Group
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. F. Hoffmann-La Roche Ltd
15.3. Danaher Corporation
15.4. Eppendorf SE
15.5. BIONEER CORPORATION
15.6. Endress+Hauser Group Services AG
15.7. Merck KGaA
15.8. Norgen Biotek Corp.
15.9. Aurora Biomed Inc.
15.10. Agilent Technologies, Inc.